Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008–2024) and pipeline phase III medications
By examining the mechanisms of action, indications, efficacy, dosing and adverse effects of psychiatic medications approved by the FDA, this review seeks to evaluate the progress and future directions in the pharmacological treatment of post-traumatic stress disorder and obsessive-compulsive
disorder.